Technology
Go Back
PreSize® Neurovascular
Technology
About
Go Back
News
The Team
Our Journey
About
Clinical Evidence
Go Back
Partners
Clinical Trials
Publications
Clinical Evidence
Log In
Contact Us
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Deny
Accept
Privacy Preferences
Essential cookies
Required
Marketing cookies
Essential
Personalization cookies
Essential
Analytics cookies
Essential
Reject all cookies
Allow all cookies
Save preferences
October 12, 2023
AI-driven technology could transform aneurysm treatment
A study found the technology to be 95% accurate when predicting where a stent would be located in the brain
Words by
Photography
Posted
October 12, 2023
Share ON SOCIAL
Note to editors
Related articles
July 9, 2025
PreSize® Neurovascular Landmark Clinical Impact Trial Receives ESMINT Endorsement
The clinical impact trial of Oxford Heartbeat's decision-support software, PreSize® Neurovascular, has been endorsed by The European Society of Minimally Invasive Neurological Therapy (ESMINT).
November 15, 2024
CEO Dr Katerina Spranger Receives Purple Plaque Honour from Innovate UK
Dr Katerina Spranger has been honoured with a Purple Plaque in recognition of winning the prestigious Innovate UK Women in Innovation Award